.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 8,440,170

« Back to Dashboard
Patent 8,440,170 protects SUPRENZA and is included in one NDA. There have been two Paragraph IV challenges on Suprenza.

This patent has three patent family members in two countries.

Summary for Patent: 8,440,170

Title:Orally disintegrating tablets with speckled appearance
Abstract: Orally disintegrating tablets containing colored granules of a water-soluble sugar which give them a speckled appearance are described. The orally disintegrating tablets with speckled appearance are readily and easy identifiable by physicians, nurses and patients.
Inventor(s): Stroppolo; Federico (Mezzovico, CH), Ardalan; Shahbaz (Mezzovico, CH)
Assignee: Alpex Pharma SA (Mezzovico, CH)
Application Number:12/811,737
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form;
Patent Metrics:
Source: PatentQuant.com
Field: Pharmaceuticals
Back Citations: 0th percentile
Forward Citations: 0th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Citius Pharms
SUPRENZA
phentermine hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL202088-001Jun 13, 2011DISCNNo8,440,170► subscribeY
Citius Pharms
SUPRENZA
phentermine hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL202088-002Jun 13, 2011DISCNNo8,440,170► subscribeY
Citius Pharms
SUPRENZA
phentermine hydrochloride
TABLET, ORALLY DISINTEGRATING;ORAL202088-003Mar 27, 2012DISCNNo8,440,170► subscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,440,170

PCT Information
PCT FiledJanuary 30, 2009PCT Application Number:PCT/EP2009/051055
PCT Publication Date:August 13, 2009PCT Publication Number: WO2009/098169

International Patent Family for Patent: 8,440,170

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office2254558► subscribe
European Patent Office2278590► subscribe
World Intellectual Property Organization (WIPO)2009098169► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc